September 2015 Monthly Test Updates

Published on 09/10/15

 The following test updates are now live:

  • MFKIN Fukuyama Congenital Muscular Dystrophy: Insertion Assay – Test discontinued.
  • GR Galactosemia, Classic: Carrier Testing (GALT Enzyme Activity), Red Blood Cells – Test discontinued.
  • MM140 Peroxisome Disorders: Sequencing Panel – Changed test name; added the following genes: ABCD1, ABCD3, ACOX1, AGPS, AGXT, AMACR, CAT, DNM1L, GNPAT, HSD17B4, PHYH, SCP2, and TRIM37; and updated CPT codes.
  • MD140 Peroxisome Disorders: Deletion/Duplication Panel – Changed test name and added the follwing gene: ABCD1.
  • MM470 Pan-Ethnic Carrier Screen: Gene Sequencing Panel– Removed VWF.
  • MM480 Pan-Ethnic Carrier Screen: Targeted Mutation Panel – Removed VWF.
  • XM010 Proportionate Short Stature/Small for Gestational Age: CytoScan SNP Array, Russell-Silver Panel, UPD14 Analysis, and Sequencing Panel – Removed SHOX2.
  • MD010 Proportionate Short Stature/Small for Gestational Age: Deletion/Duplication Panel – Removed SHOX2.
  • XM011 Proportionate Short Stature/Small for Gestational Age: CytoScan SNP Array and Sequencing Panel – Removed SHOX2.
  • MM011 Proportionate Short Stature/Small for Gestational Age: Russell-Silver Panel, UPD14 Analysis, and Sequencing Panel – Removed SHOX2.
  • MM012 Proportionate Short Stature/Small for Gestational Age: CytoScan SNP Array, Russell-Silver Panel, UPD14 Analysis, and Sequencing Panel – Removed SHOX2.
  • MM401 Melanoma: Sequencing Panel – Added BRCA2 and TP53; removed GNAQ, KRAS, MAP2K1, and PIK3CA; and updated CPT codes.
  • MD401 Melanoma: Deletion/Duplication Panel – Added BRCA2 and TP53; removed GNAQ, KRAS, MAP2K1, and PIK3CA.
  • GS Galactosemia, Classic: Panel (GALT Enzyme Activity & Galactose-1-Phosphate Quantitative), Red Blood Cells – Updated methodology, reference range, and CPT codes.
  • GT Galactosemia, Classic (Galactose-1-Phosphate Uridyltransferase Deficiency): GALT Enzyme Activity, Red Blood Cells – Updated methodology, reference range, and CPT codes.

Test Requisitions - Things to Remember
Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD9 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition.
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.

Prior Authorization Reminder
When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.